Development and growth of normal, metaplastic and dysplastic oesophageal mucosa: Biological markers of neoplasia

European Journal of Gastroenterology and Hepatology

Volumn 5, Issue 4, 1993, Pages 235-246

  Jankowski, Janusz ^a   Hopwood, David ^a   Dover, Robin ^b   Wormsley, Kenneth G ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Barrett s oesophagus; Oesophageal carcinoma; Proliferation

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MUCIN; TRANSFORMING GROWTH FACTOR ALPHA;

ADENOCARCINOMA; APOPTOSIS; BARRETT ESOPHAGUS; BLOOD GROUP LEWIS SYSTEM; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SECRETION; CELL SHAPE; CELL SIZE; DISEASE CLASSIFICATION; DUODENOGASTRIC REFLUX; DYSPLASIA; EPITHELIUM DYSPLASIA; ESOPHAGITIS; ESOPHAGUS; ESOPHAGUS CANCER; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; HUMAN; HUMAN TISSUE; LONG TERM EXPOSURE; METAPLASIA; NEGATIVE FEEDBACK; PATHOPHYSIOLOGY; PROTO ONCOGENE; REVIEW; SQUAMOUS CELL CARCINOMA; STEM CELL; STOMACH JUICE; TISSUE INJURY; TUMOR GROWTH;

EID: 0027521093     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/00042737-199304000-00008     Document Type: Review

References (103)

1. Jarvis LR, Dent J, Whitehead R: Morphometric assessment of reflux oesophagitis in fibroptic biopsy specimens. J Clin Patbol 1985, 38:44-48.
2. Ismail-Beigi F, Horton PF, Pope CE: Histological consequences of gastro-oesophageal reflux in man. Gastroenterol ogy 1970, 58:163-169.
3. Frierson HF: Histology in the diagnosis of reflux esophagitis. Gastroenterol Clin North Am 1990, 19:631-644.
4. Jankowski J, Austin w, Howat K, Hopwood D, Wormsley KG: Cell proliferation as an index of chronological age. Eur J Gastroenterol Hepatol 1991, 3:223-225.
5. Arvelo G, Marcial MA: Reflux esophagitis and Barrett’s esophagus: The diagnostic role of esophageal mucosal biopsies (a review). Bol Assoc Med J 1989, 32:352-354.
6. Jankowski J, McMenemin R, Hopwood D, Penston J, Wormsley KG: Abnormal expression of growth regulatory peptides in Barrett’s mucosa. Clin Sci 1991, 81:663-668.
7. Jankowski J, Hopwood D, Wormsley KG: Flow cytometric analysis of growth regulatory peptides in Barrett’s oesophagus. Scand J Gastroenterol 1992, 27:147-154.
8. Jankowski J, Tregaskls B, Correll C, Hopwood D, Wormsley KG: Nucleolar organiser regions in oesophageal cytology and histology. Gullet 1992, 2:85-90.
9. morita M, KUWANO H, matsuda H, MORIGUCHI S, SUGIMACHI K: Prognostic significance of argyrophilic nucleolar organiser regions in esophageal carcinoma. Cancer Res 1991, 51:5339-5341.
10. Livstone E, Sheahan D, Behar J: Studies of esophageal epithelial cell proliferation in patients with reflux esophagitis. Gastroenterology 1977, 73:1315-1319.
11. Robertson CS, Mayberry JF, Nicholson DA, James PD, Atkinson M: Value of endoscopic surveillance in the detection of neoplastic change in Barrett’s oesophagus. Br J Surg 1988, 75:760-763.
12. potet F, Duchatelle V: Barrett’s Oesophagus. In Gastrointestinal Pathology. Edited by Williams GT. Berlin: Springer-Verlag; 1990:54.
13. Atkinson M: Barrett’s oesophagus—to screen or not to screen? Gut 1989, 30:2-5.
14. Van der Veen AH, Dees J, Blankensteijn JD, Blankensteijn M: Adenocarcinoma in Barrett’s oesophagus: An over-rated risk. Gut 1989, 30:14-18.
15. Filipe M, Jankowski J: Expression of growth factors and oncogenes in Barrett’s mucosa. Ital J Gastroenterol 1993 (in press).
16. Rosen JC, Budev H, Edwards RC, Singal S, Steiger Z, Sunderson AS: Analysis of adenocarcinoma in Barrett’s oesophagus utilising a staging system. Cancer 1985, 55:1353-1360.
17. Streitz JM, Ellis FH, Gibb SP, Balogh K, Watkins E: Adenocarcinoma in Barren’s esophagus: A clinopathologic study of 65 cases. Ann Surg 1989, 213:122-125.
18. Ovaska J, Mlettlnen M, Kiyoaakso E: Adenocarcinoma arising in Barrett’s esophagus. Dig Dis Set 1989, 34:1336-1339.
19. Hameetman W, Tytgat GNJ, Houthoff HJ, van den Tweel JG: Barrett’s esophagus: Development of dysplasia and adenocarcinoma. Gastroenterology 1989, 96:1249-1256.
20. Anonymous: Studies on relationship between epithelial dysplasia and carcinoma of the oesophagus compiled by co-ordinating groups for the research of oesophageal carcinoma. Honan province and the Chinese Academy of Medical Sciences. Chin Med J 1975. 1: 110-120.
21. Matsutra H, Kuwano H, Morita M, Tsutsui S, Kido Y, Mori M, et al.: Predicting recurrence time of esophageal carcinoma through assessment of histologic factors and DNA ploidy. Cancer 1991. 67: 1406-1411.
22. Hamilton SR: Reflux esophagitis and Barrett esophagus. In Gastrointestinal Pathology. Edited by Goldman H, Appelman HD, Kaufman N. Baltimore: Williams and Wilkias; 1990:11-60.
23. Wright NA, Alison MR: The Biology of Epithelial Cell Populations. Oxford: Clarendon Press: 1984
24. Jankowski J, Austin W, Howat K, Coghill G, Hopwood D, Dover R, et al: Proliferating ceil nuclear antigen in oesophageal mucosa: Comparison with autoradiography. Eur J Gastroenterol Hepatol 1992. 4:579-584.
25. Jankowski J, Murphy S, Coghill G, Grant a, Wormsley KG, Sanders DSA, et al.: Epidermal growth factor receptors in oesophagus. Gut 1992. 4:439-443
26. Hopwood D, Jankowski J: Flow cytometric assessment in oesophageal epithelial cells: Application and potential in health and disease. Gullet 1992. 2:95-100.
27. Jankowski J, Wright NA: Epithelial stem cells; in gastrointestinal structure, function and adaptation. Sem Cell Biol 1993 (in press).
28. Dent J: Recent views on the pathogenesis of gastro-oesophageal reflux disease. In Bailliere’s Clinical Gastroenterology Oesophageal Disorders. Edited by Tytgat GNJ. London: Bailliere. 1987.
29. Jankowski J, Tregaskis B, Coghill G, Hopwood D, Wormsley KG: Epidermal growth factor in the oesophagus in health and disease. Gut 1992. 33 1448-1453.
30. Filipe MI, Jankowski J, Patel K, Hanby A: Expression of TNF and TGF β in normal, metaplastic and neoplastic cells in the oesophagus. Gut 1992. 33:345.
31. Jankowski J, Coghill G, Hopwood D, Wormsley KG: Oncogenes and anti-oncogenes in oesophageal adenocarcinomas. Gut 1992. 33:1033-1038.
32. Jankowski J, McLellan L, Hopwood D, Wormsley KG: Expression of enzymes in oesophageal diseases. Gullet 1992, 2:109-115.
33. Hopwood D, Jankowski J, Milne G: Horseradish peroxidase as an indicator of permeability in the oesophageal mucosa. Histochem J 1991, 45:654-658.
34. Jankowski J, Coghill G, Hopwood D, Wormsley KG: Lewis blood group antigens and EGF-R in the oesophagus. Gullet 1993, 3:16-22.
35. Craddock VM: Aetiology of oesophageal carcinoma: Some operational factors. Eur J Cancer Prevent 1992, 1:89-103.
36. DeNardi FG, Riddell RH: The normal esophagus. Am J Surg Pathol 1991, 15:296-309.
37. Goetsch E: The structure of the mammalian oesophagus. Am J Anat 1910, 10:1-40.
38. Jankowski J, Dover R: The assessment of proliferation, differentiation and cell death in the oesophagus. Gullet 1993, 3:1-15.
39. Williams GT: Programmed cell death: Apoptosis and oncogenesis. Cell 1991, 65:1097-1098.
40. Goldstein JL, Schleslnger PK, Mozwecz HL, Layden TJ: Esophageal mucosal resistance: A factor in esophagitis. Gastroenterol Clin North Am 1990, 19:565-586.
41. Salo JA, Lehto AP, Myllarniemi HS, Kivalaakso EO: Morphological alterations in tryptic esophagitis; an experimental and light microscopic and scanning and transmission electron microscopic study in rabbits. J Surg Res 1990, 49:14-17.
42. Salisbury JR, Whimster WF: Pathology of oesophageal disease. In Management of Oesophageal Cancer. Berlin: Springer-Verlag; 1989.
43. Bennett JR: The oesophagus. In Recent Advances in Gastroenterology. Edited by Pounder R. Edinburgh: Churchill-Livingstone, 1990.
44. Tobey NA, Orlando RC: Mechanisms of acid injury to rabbit oesophageal epithelium. Gastroenterology 1991, 101:1220-1228.
45. Eastwood GL: Epithelial renewal. In Premalignant Conditions of the Gastrointestinal Tract Edited by Eastwood GI. London: Elsevier Publications; 1991.
46. Erksen CA, Cuschlerei A: Diagnostic tests for gastro-oesophageal reflux. In Reflux Oesophagitis. Edited by Hennessv TPJ, Cuschierei A, Bennett JR. London: Butterworths; 1989.
47. Rossiter A, Guelrud M, Souney PF, Mendosa S, Rossiter G, Gelrld D: Cck in the oesophagus. Scand J Gastroenterol 1991, 26:572-576.
48. Stoker DL, Williams JG: Alkaline reflux oesophagitis. Gut 1991, 32:1090-1092.
49. Jankowski J, Prlngle R, Hopwood D, Wormsley KG: Increased expression of epidermal growth factor receptors in Barrett’s esophagus associated with alkaline reflux. Am J Gastroenterol 1993 (in press).
50. Tytgat GNJ, Bianchi Porro G, Feussner H, Pace F, Richter JE, Slew art JR: Long-term strategy for the treatment of gastro-oesophageal reflux disease. Gastroenterol Int 1991, 4:21-32.
51. Hou J, Zuo LF, Liu HX, Li SS. Lin YZ, Wang DZ, et al.: Flow cytometry in analysis of precancerous lesions of the esophagus. Chung Hua Chung Liu Tsa Chih 1988, 10:105-108.
52. Wahrendorf J, Chang-Clause J, Liaing QS, Rei YG, Munoz N, Crespi M, et al.: Precursor lesions of oesophageal cancer in young people in a high-risk population in China. Lancet 1989, ii:1239-1241.
53. Bogomoietz WV: Superficial squamous cell carcinoma of esophagus: A report of 76 cases and review of the literature. Am J Surg Pathol 1989, 13:535-546.
54. Misumi A, Harada K, Murakami A, Arima K, Kondo H, Akagi M, et al.: Early diagnosis of esophageal cancer. Ann Surg 1989. 210:732-739.
55. Yoshinaka H, Shimazu H, Fukumoto T, Baba M: Superficial esophageal carcinoma: A clinopathological review of 59 cases. Am J Gastroenterol 1991, 86.1413-1418.
56. Kato H, Tachimori Y, Watanabe H, Ishkawa T, Itabashi M: Superficial esophageal carcinoma. Cancer 1990, 66: 2319-2323.
57. Jacob P. Kahrilas PJ, Desai T, Hidvegi D, Walloch J. Yokoo H, et al.: Natural history and significance of esophageal squamous cell dysplasia. Cancer 1990, 65:2731-2739.
58. Jaskiewicz K: Oesophageal carcinoma: Cytopathology and nutritional aspects in aetiology. Anticancer Res 1989, 9:1847-1852.
59. Jaskiewicz K, Louwrens HD, Van Wyk MJ, Woodroof CL: Oesophageal mucosal pathology in a population at risk for gastric and oesophageal carcinoma. Anticancer 1989, 9:1191-1196.
60. Nabeya K: Early diagnosis of esophageal cancer. Hepatogas troenterology 1990, 37:368-370.
61. Spechler SJ: Barrett esophagus: A sequelae of chemotherapy. Ann Intern Med 1991, 114:243-244.
62. Hamilton SR, Yardley JA: Regeneration of cardia type mucosa and acquisition of Barrett mucosa after esophagogastrostomy. Gastroenterology 1984, 86:461-467.
63. Boffa LC, Bolognesi C: Principles of carcinogenesis. In Pre-malignant Conditions of the Gastrointestinal Tract. Edited by Eastwood G. London: Elsevier; 1990:3-21.
64. Garewal HS, Sampuner R, Liu Y, Trent JM: Chromosomal rearrangements in Barrett’s esophagus. Cancer Genet Cytogenet 1989, 42:281-286.
65. Mottet NK: Mucin biosynthesis by chick and human oesophagus during ontogenic metaplasia. J Anat 1970. 107:49-66.
66. Qualman SJ, Murray RD, McClung HJ, Lucas J: Intestinal metaplasia is age related in Barrett’s esophagus. Arch Pathol Lab Med 1990, 114:1236-1240.
67. Slaga TJ: Mechanisms of chemical carcinogenesis. In Clinical Oncology: Boston: Williams and Wilkins; 1991:31-37.
68. Rubio CA, Aberg B: Further studies on the musculo-fibrous anomaly of the Barrett’s mucosa in the oesophageal cancer. Pathol Res Pract 1991, 187:1009-1013.
69. Robey SS, Hamilton SR, Gupta PK, Erozan YS: Diagnostic value of cytopathology in Barren esophagus and associated carcinoma. Am J Clin Pathol 1988, 89:493-498.
70. Riddeli RH, Goldman H, Ransohoff DF: Dysplasia in inflammatory bowel disease: Standardised classification with provisional clinical applications. Hum Pathol 1983, 13:931-968.
71. Katzka DA: Barrett’s esophagus: Detection and management. Gastroenterol Clin North Am 1989, 18:339-357.
72. Wang HH, Antoniou DA, Goldman H: Comparative features of esophageal and gastric adenocarcinomas: Recent changes in type and frequency. Hum Pathol 1986. 17: 482-487.
73. Potet F, Flejou JF, Gervaz H, Paraf F: Adenocarcinoma of the lower esophagus and the esophagogastric junction. Semin Diag Pathol 1991. 8:126-136.
74. Gottfried MR, McClave SA, Boyce HW: Incomplete intestinal metaplasia in the diagnosis of columnar lined esophagus (Barrett’s esophagus). Am J Clin Patbol 1989. 92: 741-746.
75. Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA: Prevalence of columnar-lined (Barrett’s) esophagus: Comparison of population-based clinical and autopsy findings. Gastro enterology 1990. 99:918-922.
76. Polepalle SC, McCallum RW: Barrett’s esophagus: Current assessment and future perspectives. Gastroenterol Clin North Am 1990, 19: 733-745.
77. reid BJ, weinstein WM, lewin KJ, Haggitt RC, vanDeventer G, DenBesten L, et al.: Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett’s esophagus without grossly recognisable neoplastic lesions. Gastroenterology 1988. 94:81-90.
78. Jankowski J, Hopwood D, Wormsley KG: The expression of growth regulatory peptides in gastro-oesophageal diseases. Dig Dis 1993 (in press).
79. Jankowski J, Al-Rawi H, Johnston D, Hopwood D, Filipe MI, Coghill G, et al.: Growth regulatory peptides in the gastric mucosa. Clin Sci 1992, 82:581-587.
80. Altorki NK, Sunagawa M, Little AG, Skinner DB: High-grade dysplasia in the columnar-lined esophagus. Am J Surg 1991. 161:97-99.
81. Wright NA, Pike C, Elia G: Induction of a novel growth-factor secreting cell lineage by mucosal ulceration in human gastro-intestinal cells. Nature 1990, 343:82-85.
82. Hanby A, Jankowski J, Poulsom R, Singh S, Elia G, Wright NA: Expression of trefoil peptides in oesophageal mucosa in health and disease. Human Pathol 1993 (in press).
83. Schuller HM: The signal transduction model of carcinogenesis. Biochem Pharmacol 1991, 42:1511-1523.
84. Kelly S: Differential endocrine populations in intestinal and gastric type Barrett’s dysplasia in the presence of adenocarcinoma [abstract]. J Pathol 1992, 65:31.
85. Kozarek RA: Complications of reflux esophagitis and their medical management. Gastroenterol Clin North Am 1990, 19:713-725.
86. Gallagher RE: Control of differentiation. In Clinical Oncology. Boston: Williams and Wilkins; 1991:14-21.
87. Miros M, Kerlin P, Walker N: Only patients with dysplasia progress to adenocarcinoma in Barrett’s oesophagus. Gut 1991, 32:1441-1446.
88. Geisinger KR, Teot LA, Richyer JE: A comparative cytopathologic and histopathologic study of atypia, dysplasia, and adenocarcinoma in Barrett’s esophagus. Cancer 1992, 69:8-16.
89. Garewal HS, Sampliner R, Gerner E, Steinbronn K, Alberts D, Kendall D: Ornithine decarboxylase activity in Barrett’s esophagus: A potential marker for dysplasia. Gastroenterology 1988, 94:819-821.
90. McKenzie SJ: Diagnostic utility of oncogenes and their products in human cancer. Biochim Biophys Acta 1991, 1072:193-214.
91. Drews RE, Schnipper LE: Development of tumour heterogeneity. In Clinical Oncology. Boston: Williams and Wilkins; 1991:123-130.
92. Cune MJ: Biology of disease: Molecular diagnosis of human cancer. In Pathology Reviews. Clifton Humana Press Inc: 1990:191-203.
93. Bruckstein AH: Carcinoma of the oesophagus. Postgrad Med 1990, 87:125-134.
94. Seitz JF: Endoscopic detection of dysplasia and early esophageal cancer: Results of prospective study with toluidine blue vital staining in 100 tobacco and alcohol abusers. Gastroenterol Clin Biol 1990, 14:15-21
95. De Baecque C, Potet F, Molas G, Flejou JF, Barbier P, Martignon C: Superficial adenocarcinoma of the oesophagus arising in Barrett’s mucosa with dysplasia: A clinico-pathologic study of 12 patients. Histopathology 1990, 16: 213-220.
96. Robaszkiewicz P, Reid BJ, Volant A, Cauvin JM, Rabinovttch PS, Gouerou H: Flow cytometry in Barrett’s mucosa. Gas troenterology 1991. 101:1588-1593.
97. Kohn KC, Liotta LA: Local invasion and metastases. In Clinical Oncology. Boston: Williams and Wilkins: 1991:131-137.
98. Jankowski J: Barrett’s metaplasia: Acute and chronic adaptive responses in the oesophagus. Gut 1993 (in press).
99. Tsuda T, Tahara E, Kajiyama G, Sakamoto H, Terada M, Sugimura T: High incidence of coamplification of Hst-1 and int-2 genes in human oesophageal carcinoma. Cancer Res 1989, 49:5505-5508.
100. Hamburger AW: Cell transformation. In Clinical Oncology. Boston: Williams and Wilkins; 1991:22-28.
101. Chen S, Chou C, Wong F, Chang C, Hu C: Over expression of EGF-R and IGF-R type 1 and autocrine stimulation of human oesophageal cancer cells. Cancer Res 1991, 51:1898-1903.
102. Casson AG, Mukhopadhyay T, Cleary KR, Rp JY, Levin B, Roth JA: P53 gene mutations in Barrett’s epithelium and esophageal cancer. Cancer Res 1991, 51:4495-4499.
103. Watson JV: Tumour growth dynamics. Br Med Bull 1991. 47:47-63.